The global Proteomics Market is valued at an estimated USD 33.6 billion in 2024 and is projected to reach USD 60.5 billion by 2029 at a CAGR of 12.4% during the forecast period. The proteomics market is experiencing robust growth, driven by the rising demand for personalized medicine, advancements in drug discovery, increasing government and private funding, and the development of biologics and biosimilars. Proteomics plays a crucial role in personalized medicine, aiding in biomarker discovery and drug target identification, while technological advancements in single-cell proteomics and bioinformatics further propel the market. However, the high cost of instruments like mass spectrometers and chromatography systems poses a restraint, particularly for small enterprises. Opportunities arise from advancements in bioinformatics, with tools like MaxQuant and AI-driven algorithms, such as AlphaFold, enhancing protein analysis and drug design. Despite these advances, challenges remain in managing the vast amount of proteomics data and ensuring standardization and interoperability across platforms. The spectroscopy segment dominated the proteomics market in 2023, while immunoassay reagents are expected to see significant growth due to their role in disease detection. North America led the global proteomics market, driven by the presence of pharmaceutical companies and growing precision medicine demand. Key players in the market include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, Danaher Corporation, and others.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731
Browse in-depth TOC on “Proteomics Market“
707 – Tables
49 – Figures
578 – Pages
Thermo Fisher Scientific, Inc.: Leading Innovation in Proteomics
Thermo Fisher Scientific, Inc. (US) holds a dominant position in the proteomics market due to its diverse product portfolio, global presence, and strategic growth initiatives. The company employs both organic and inorganic strategies, including partnerships and acquisitions, to maintain its leadership. Thermo Fisher emphasizes innovation in proteomics technologies, such as the March 2024 launch of the Thermo Scientific Stellar Mass Spectrometer, a cutting-edge tool designed to enhance throughput, sensitivity, and usability in proteomics research, accelerating translational omics and breakthrough discoveries.
Danaher Corporation: Advancing Proteomics through SCIEX
Danaher Corporation (US) is a key player in the proteomics market, operating through its subsidiary SCIEX, which specializes in developing analytical instruments, software, and services for proteomics research. Danaher’s strategic mergers and acquisitions have solidified its position as a top provider of proteomics tools and reagents, enabling scientists to explore protein roles in various biological processes. The company’s proteomics solutions support advancements in life sciences, diagnostics, and other key sectors.
Agilent Technologies Inc.: Innovating Proteomics Research Solutions
Agilent Technologies Inc. (US) is a global leader in proteomics, offering a wide range of scientific instruments, consumables, software, and tools. Known for its reliability and innovation, Agilent’s diversified portfolio enables comprehensive proteomics research, covering instrumentation, consumables, and services. Agilent supports advancements in personalized medicine, drug development, and biomarker discovery by empowering researchers to analyze proteins and gain new insights into complex biological processes.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=731
Technology Segment: Spectroscopy Dominates the Proteomics Market
The proteomics market is segmented by technology into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, protein fractionation, and other technologies. In 2023, the spectroscopy segment led the market, driven by its ability to quantify complex protein structures at scale and its integration capabilities with other technologies. Spectroscopy is further divided into mass spectrometry, NMR spectroscopy, and CD spectroscopy, with mass spectrometry being the key contributor to this segment’s dominance.
Reagent Segment: Immunoassay Reagents Lead the Market
The proteomics market is segmented by reagents into protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, protein fractionation reagents, and other reagents. In 2023, the immunoassay reagents segment held the largest market share due to their wide availability, increased use in biomarker discovery and disease diagnostics, and the need for fast and accurate detection of diseases, especially in early stages.
Service Segment: Core Proteomics Services Hold the Largest Share
The proteomics market is segmented by service type into core proteomics services and bioinformatics services. In 2023, the core proteomics services segment dominated the market, driven by the rising need for advanced data analysis tools, the growth of contract research organizations (CROs), and the development of modern software platforms that handle complex proteomic datasets, facilitating data interpretation and analysis.
Software Segment: Bioinformatics Tools Lead
The software segment of the proteomics market is divided into bioinformatics tools and bioinformatics databases. The bioinformatics tools segment held the largest market share in 2023, attributed to the growing demand for handling complex biological data, integrating multiomics data, and improving computational power and storage capabilities. The adoption of high-throughput technologies further contributed to the growth of bioinformatics tools.
Application Segment: Clinical Diagnostics Drives Growth
The proteomics market is segmented by application into drug discovery, clinical diagnostics, and other applications. In 2023, the clinical diagnostics segment led the market, driven by advancements in biomarker technologies and the ability of proteomics to identify and quantify proteins at early stages of diseases. These capabilities have increased the reliability of clinical diagnostics, further boosting the segment’s growth.
End User Segment: Biopharmaceutical Companies Lead
The proteomics market is segmented by end user into hospitals, clinical laboratories, biopharmaceutical companies, academic & research institutes, and others. In 2023, the biopharmaceutical companies segment dominated the market, driven by increasing research collaborations, clinical trial developments, and regulatory demands for in-depth protein analysis.
Regional Insights: North America Leads, Asia Pacific Sees Rapid Growth
The global proteomics market is segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2023, North America held the largest market share, while Asia Pacific is expected to experience the fastest growth. The Asia Pacific region faces a high prevalence of chronic diseases like cancer and cardiovascular disorders, and the rising demand for better diagnostics and personalized medicine is driving growth in proteomics research in this region.
For more information, inquire now! Inquire Now
Media ContactCompany Name: MarketsandMarkets™ Research Private Ltd.Contact Person: Mr. Rohan SalgarkarEmail: Send EmailPhone: 18886006441Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445City: FloridaState: FloridaCountry: United StatesWebsite: https://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html
